Sign in
WithdrawnNo phase

Arterial Pressure and Stress-Dose Steroids in Cardiac Arrest.

Key facts

Who runs it
University of Athens
Where
Greece3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
Dec 2025
Expected to end
Dec 2026
Type of study
Observational, 2 groups
Treatments tested
  • Vasopressin Steroids Epinephrine
Record updated
30 March 2025
Why it stopped
No funding could be obtained for this study

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Adult patients with vasopressor-requiring inhospital cardiac arrest according to guidelines for resuscitation 2005, defined as:
  • epinephrine requirement for ventricular fibrillation/tachycardia
  • or asystole, or
  • pulseless electrical activity

Who cannot take part

  • Pre-arrest treatment with intravenous corticosteroids
  • Previous enrollment in or exclusion from the 2 studies included in the analysis
  • Terminal illness or do-not resuscitate status
  • Cardiac arrest due to exsanguination
  • Cardiac arrest before hospital admission
  • Age < 18 years

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Early stress-dose steroids are of uncertain efficacy in cardiac arrest. The current authors plan to conduct a pertinent mediation analysis using prospectively collected data from 2 prior randomized clinical trials of in-hospital cardiac arrest. These trials reported positive results on the vasopressin-steroids-epinephrine (VSE) combination. The current analysis is aimed at identifying mediators of the benefit associated with VSE, potentially attributable to its stress-dose steroid subcomponent. Tested mediators will include arterial pressure in the early postresuscitation period (primary), and arterial blood lactate in the early postresuscitation period and renal failure free days (secondary).

The 2 groups in the trial

  • Vasopressin Steroids Epinephrine (VSE)

    Patients with in-hospital cardiac arrest treated with vasopressin, methylprednisolone, and epinephrine during cardiopulmonary resuscitation, and also with stress-dose hydrocortisone for postresuscitation shock.

    Treatment: Vasopressin Steroids Epinephrine

  • Control

    Patients with in-hospital cardiac arrest treated with normal saline placebo, normal saline placebo, and epinephrine during cardiopulmonary resuscitation, and also with normal saline placebo for postresuscitation shock.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Arterial Pressure and Stress-Dose Steroids in In-hospital Cardiac Arrest: a Mediation Analysis of Prior Randomized Clinical Trial Data.
Record updated
30 March 2025